IQVIA Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on IQVIA Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how IQVIA Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with IQVIA Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
IQVIA Holdings Inc (IQVIA) is a global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company offers a range of solutions powered by IQVIA Connected Intelligence, which includes high-quality health data, healthcare-grade AI, advanced analytics, and technology. IQVIA's major services include analytics-driven clinical development, real-world solutions, and technology-enabled commercial operations. The company serves biotech, medical device, and pharmaceutical companies, as well as government agencies and healthcare stakeholders. IQVIA operates through a network of channel partners and distribution networks to deliver its services. The company has operations in Asia, Europe, the Americas, and Africa. IQVIA is headquartered in Durham, North Carolina, the US.
Headquarters
United States of America
Address
2400 Ellis Road, Durham, North Carolina, 27703
Website
ir.iqvia.com
Telephone
1 919 9982000
No of Employees
93,000
Industry
Business and Consumer Services
Ticker Symbol & Exchange
IQV (NYSE)
Revenue (2024)
$16.3B
5.9%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-0.9%
(2024 vs 2023)
Market Cap*
$32.2B
Net Profit Margin (2024)
XYZ
-6.4%
(2024 vs 2023)
* As of and is in US$
Products and Services
| Products | Services | Brands |
|---|---|---|
| Clinical | Solutions: | Iqvia |
| Planning Suite | Project Management and Clinical Monitoring | Iqvia Core |
| Grant Plan | Clinical Trial Support | IQVIA Connected Intelligence |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In May, the company partnered with Kexing Biopharm to enhance a global, multi-product biosimilar development and commercialization program. |
| 2026 | New Products/Services | In March, the company launched IQVIA.ai, a unified agentic AI platform powered by NVIDIA. |
| 2026 | Contracts/Agreements | In February, the company entered into an agreement to acquire the Drug Discovery Assets of Charles River Laboratories, a pharma company. |
Competitor Comparison
| Key Parameters | IQVIA Holdings Inc | Deloitte Touche Tohmatsu Ltd | Accenture Plc | International Business Machines Corp | Cognizant Technology Solutions Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United Kingdom | Ireland | United States of America | United States of America |
| City | Durham | London | Dublin | Armonk | Teaneck |
| State/Province | North Carolina | Greater London | - | New York | New Jersey |
| No. of Employees | 93,000 | 473,050 | 779,000 | 286,800 | 357,600 |
| Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ari Bousbib | Chief Executive Officer; Chairman | Executive Board | 2016 | 64 |
| Mike Fedock | Chief Financial Officer; Executive Vice President | Senior Management | - | - |
| Keriann Cherofsky | Senior Vice President; Chief Accounting Officer; Controller | Senior Management | 2026 | - |
| Trudy Stein | Executive Vice President; Chief Human Resources Officer | Senior Management | 2016 | - |
| Jeffrey Spaeder | Chief Medical and Scientific Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer